Company: Wugen Inc.
Job title: Chief Medical Officer
Fireside Chat: An Update on Novel Cellular Immunotherapies to Tackle Head and Neck Cancer 3:00 pm
Sharing rationale for targeting neoantigens for anti-tumor vaccination Summarizing therapeutic development of neoantigen vaccination for oncology to date Overview results of neoantigen vaccination application for H&N tumors Outlining next steps to optimize neoantigen vaccination for head and neck tumorsRead more
day: Day Two